Phase II study of the histone deacetylase inhibitor belinostat (PXD101) for the treatment of myelodysplastic syndrome (MDS) - Concepedia

Concepedia

Publication | Closed Access

Phase II study of the histone deacetylase inhibitor belinostat (PXD101) for the treatment of myelodysplastic syndrome (MDS)

63

Citations

19

References

2011

Year

Amanda F. Cashen, Mark Juckett, Alcee Jumonville, Mark R. Litzow, Patrick J. Flynn, John R. Eckardt, Betsy LaPlant, Kristina Laumann, Charles Erlichman, John F. DiPersio

Annals of Hematology

Hematological MalignancyChromatinOncologyMyelodysplastic SyndromeMedicineHematologyPharmacologyPathologyPhase Ii StudyEpigenetic RegulationCancer ResearchTumor BiologyMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1